Literature DB >> 20096072

Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis-related mouse colon cancer models.

Jirí Svec1, Peter Ergang, Václav Mandys, Milan Kment, Jirí Pácha.   

Abstract

Elevated levels of survivin, telomerase catalytic subunit (TERT), integrin-linked kinase (ILK), cyclooxygenase 2 (COX-2), inducible nitric oxide synthase (iNOS) and the regulatory factors c-MYB and Tcf-4 are often found in human cancers including colorectal cancer (CRC) and have been implicated in the development and progression of tumorigenesis. The aim of this study was to determine the expression of these genes in mouse models of sporadic and colitis-associated CRC. To address these issues, we used qRT-PCR approach to determine changes in gene expression patterns of neoplastic cells (high-grade dysplasia/intramucosal carcinoma) and surrounding normal epithelial cells in A/J and ICR mouse strains using laser microdissection. Both strains were injected with azoxymethane and ICR mice were also given drinking water that contained 2% dextran sodium sulphate. In both sporadic (A/J mice) and colitis-associated (ICR mice) models of CRC, the levels of TERT mRNA, COX-2 mRNA and Tcf-4 mRNA were higher in neoplastic cells than in surrounding normal epithelial cells. In contrast, survivin mRNA was upregulated only in neoplastic cells from A/J mice and ILK mRNA was upregulated only in neoplastic cells from ICR mice. However, the expression of iNOS mRNA was similar in normal and neoplastic cells in both models and c-MYB mRNA was actually downregulated in neoplastic cells compared with normal cells in both models. These findings suggest that the genetic background and/or the molecular mechanisms of tumorigenesis associated with genotoxic insults and colonic inflammation influence the gene expression of mTERT, COX-2, Tcf-4, c-MYB, ILK and survivin in colon epithelial neoplasia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096072      PMCID: PMC2812727          DOI: 10.1111/j.1365-2613.2009.00698.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  39 in total

1.  Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis.

Authors:  P Yan; E P Saraga; H Bouzourene; F T Bosman; J Benhattar
Journal:  J Pathol       Date:  2001-01       Impact factor: 7.996

Review 2.  Validating survivin as a cancer therapeutic target.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

3.  Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development.

Authors:  J Ohno; Y Horio; Y Sekido; Y Hasegawa; M Takahashi; J Nishizawa ; H Saito; F Ishikawa; K Shimokata
Journal:  Carcinogenesis       Date:  2001-05       Impact factor: 4.944

4.  Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.

Authors:  T Zhang; T Otevrel; Z Gao; Z Gao; S M Ehrlich; J Z Fields; B M Boman
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

Review 5.  The Yin-Yang of TCF/beta-catenin signaling.

Authors:  N Barker; P J Morin; H Clevers
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

6.  The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.

Authors:  A Duval; S Rolland; E Tubacher; H Bui; G Thomas; R Hamelin
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

7.  Expression of human telomerase subunit genes in primary lung cancer and its clinical significance.

Authors:  M Arinaga; S Shimizu; K Gotoh; N Haruki; T Takahashi; T Takahashi; T Mitsudomi
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

8.  Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.

Authors:  Y Kishimoto; T Morisawa; A Hosoda; G Shiota; H Kawasaki; J Hasegawa
Journal:  J Exp Clin Cancer Res       Date:  2002-06

9.  Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients.

Authors:  Jerzy Nowak; Danuta Januszkiewicz; Krzysztof Lewandowski; Karina Nowicka-Kujawska; Monika Pernak; Jolanta Rembowska; Tomasz Nowak; Jacek Wysocki
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-01       Impact factor: 2.566

10.  Chemopreventive effects of the standardized extract (DA-9601) of Artemisia asiatica on azoxymethane-initiated and dextran sulfate sodium-promoted mouse colon carcinogenesis.

Authors:  Hyun Soo Kim; Joydeb Kumar Kundu; Jeong-Sang Lee; Tae-Young Oh; Hye-Kyung Na; Young-Joon Surh
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

View more
  5 in total

1.  TERT's role in colorectal carcinogenesis.

Authors:  Andrew J Pellatt; Roger K Wolff; Jennifer Herrick; Abbie Lundgreen; Martha L Slattery
Journal:  Mol Carcinog       Date:  2012-02-21       Impact factor: 4.784

2.  The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.

Authors:  Mariangela De Robertis; Emanuela Massi; Maria Luana Poeta; Simone Carotti; Sergio Morini; Loredana Cecchetelli; Emanuela Signori; Vito Michele Fazio
Journal:  J Carcinog       Date:  2011-03-24

3.  Effect of Angelica sinensis Root Extract on Cancer Prevention in Different Stages of an AOM/DSS Mouse Model.

Authors:  Bochen Zhao; Qian Kang; Yu Peng; Yuanping Xie; Cheng Chen; Bingshao Li; Qing Wu
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

4.  Regulation of 11β-hydroxysteroid dehydrogenase type 1 and 7α-hydroxylase CYP7B1 during social stress.

Authors:  Martin Vodička; Peter Ergang; Anna Mikulecká; Lenka Řeháková; Petra Klusoňová; Jakub Makal; Matúš Soták; Jana Musílková; Petr Zach; Jiří Pácha
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

5.  Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.

Authors:  Vardit Moshayoff; Ouriel Faktor; Luigi Laghi; Giuseppe Celesti; Tamar Peretz; Dan Keret; Dana Cohen; Eran Israeli
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.